Credit: Patrick J. Lynch, medical illustrator; C. Carl Jaffe, MD, cardiologist. Adjunctive left atrial appendage (LAA) ligation failed to increase the efficacy of catheter pulmonary vein isolation ...
SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial
Redwood City, CA. SentreHEART, Inc., the manufacturer of the LARIAT Suture Delivery Device, announced that it has received approval for an Investigational Device Exemption (IDE) from the U.S. Food and ...
Please provide your email address to receive an email when new articles are posted on . Outcomes for ablation of persistent AF by pulmonary vein antral isolation (PVAI) alone have been historically ...
The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
REDWOOD CITY, Calif., SentreHEART, Inc. announced that it has received CE Mark approval for the LARIAT Surgical Left Atrial Appendage (LAA) Suture Delivery Device. The LARIAT Surgical LAA device is a ...
Loyola Medicine is enrolling patients in a landmark clinical trial of a new procedure to treat atrial fibrillation, the most common type of irregular heartbeat. The clinical trial will combine the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback